Wednesday, December 25th, 2019
Sheena McKenzie, - CNN
When leaders from the European Council gathered for a group photo in Brussels last week, it was hard to miss the class newbie.
Wednesday, December 25th, 2019
Justin Mikulka, - EcoWatch
In over their heads with debt, U.S. shale oil and gas firms are now moving from a boom in fracking to a boom in bankruptcies. This trend of failing finances has the potential for the U.S. public, both at the state and federal levels, to be left on the hook for paying to properly shut down and clean up even more drilling sites.
Expect these companies to try reducing their debt through the process of bankruptcy and, like the coal industry, attempting to get out of environmental and employee-related financial obligations.
In October, EP Energy — one of the largest oil producers in the Eagle Ford Shale region in Texas —
Wednesday, December 25th, 2019 Hannah Fresques , - ProPublica Doctors who receive money from drugmakers related to a specific drug prescribe that drug more heavily than doctors without such financial ties, a new ProPublica analysis found. The pattern is consistent for almost all of the most widely prescribed brand-name drugs in Medicare, including drugs that treat diabetes, asthma and more. The financial interactions include payments for delivering promotional talks, consulting and receiving sponsored meals and travel. The 50 drugs in our analysis include many popular and expensive ones. Thirty-eight of the drugs have yearly costs exceeding $1,000 per patient, and many topped the list that are most costly for the Medicare Part D drug program. Take Linzess, a drug to treat irritable bowel syndrome and severe constipation. From 2014 to 2018, the drug’s makers, Allergan and Ironwood, spent nearly $29 million on payments to doctors related to Linzess, mostly for meals and promotional speaking fees. ProPublica’s analysis found that doctors who received payments related to Linzess in 2016 wrote 45% more prescriptions for the drug, on average, than doctors […] Wednesday, December 25th, 2019 Motoko Rich and Makiko Inoue, - The New York Times IWAKI, JAPAN — The overpowering earthquake and tsunami that ripped through northern Japan in March 2011 took so much from Tatsuo Niitsuma, a commercial fisherman in this coastal city in Fukushima Prefecture. The tsunami pulverized his fishing boat. It demolished his home. Most devastating of all, it took the life of his daughter. Now, nearly nine years after the disaster, Mr. Niitsuma, 77, is at risk of losing his entire livelihood, too, as the government considers releasing tainted water from a nuclear power plant destroyed by the tsunami’s waves. Prime Minister Shinzo Abe’s cabinet and the Tokyo Electric Power Company — the operator of the Fukushima Daiichi plant, where a triple meltdown led to the worst nuclear crisis since Chernobyl — must decide what to do with more than one million tons of contaminated water stored in about 1,000 giant tanks on the plant site. On […] Tuesday, December 24th, 2019 Michael Irving, - New Atlas/UCLA Research led by the University of California, Los Angeles (UCLA) has uncovered a new process that may help explain how Type 2 diabetes develops. In tests on live mice and human cells in the lab, the team found a new mechanism besides insulin resistance and high glucose levels that triggers pancreatic cells to begin overproducing insulin. Type 2 diabetes is the form of the disease that’s usually a result of lifestyle choices, such as poor diet and not enough exercise. It involves a kind of vicious cycle of insulin – beta cells in the pancreas produce too much insulin, which causes the body to become resistant to it. That in turn means the beta cells could produce even more to compensate. It was long thought that high glucose levels – most commonly caused by eating too much sugary and fatty foods – was the trigger for the beta cells to begin overproducing insulin. But it’s also been shown in the past that even beta cells isolated in a lab dish can over-secrete insulin, without glucose playing a part. So […]Books by Stephan
Remote Viewing the Year 2060
November 28, 2024 Background Briefing with Ian Masters